237 related articles for article (PubMed ID: 9293792)
1. False-negative fluorine-18-FDG PET in metastatic carcinoid.
Jadvar H; Segall GM
J Nucl Med; 1997 Sep; 38(9):1382-3. PubMed ID: 9293792
[TBL] [Abstract][Full Text] [Related]
2. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
3. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
Hoegerle S; Altehoefer C; Ghanem N; Koehler G; Waller CF; Scheruebl H; Moser E; Nitzsche E
Radiology; 2001 Aug; 220(2):373-80. PubMed ID: 11477239
[TBL] [Abstract][Full Text] [Related]
4. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Fiebrich HB; Brouwers AH; Koopmans KP; de Vries EG
Eur J Cancer; 2009 Sep; 45(13):2312-5. PubMed ID: 19477116
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
6. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T
Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212
[No Abstract] [Full Text] [Related]
7. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
[TBL] [Abstract][Full Text] [Related]
8. 'False-positive' uptake of FDG in a hepatic adenoma.
Patel PM; Alibazoglu H; Ali A; Fordham E; LaMonica G
Clin Nucl Med; 1997 Jul; 22(7):490-1. PubMed ID: 9227877
[No Abstract] [Full Text] [Related]
9. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
Vitola JV; Delbeke D; Sandler MP; Campbell MG; Powers TA; Wright JK; Chapman WC; Pinson CW
Am J Surg; 1996 Jan; 171(1):21-6. PubMed ID: 8554144
[TBL] [Abstract][Full Text] [Related]
10. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
Yonekura Y; Benua RS; Brill AB; Som P; Yeh SD; Kemeny NE; Fowler JS; MacGregor RR; Stamm R; Christman DR; Wolf AP
J Nucl Med; 1982 Dec; 23(12):1133-7. PubMed ID: 6982967
[TBL] [Abstract][Full Text] [Related]
11. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
[TBL] [Abstract][Full Text] [Related]
12. Staging recurrent metastatic colorectal carcinoma with PET.
Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
14. Functional imaging of malignant paragangliomas and carcinoid tumours.
Le Rest C; Bomanji JB; Costa DC; Townsend CE; Visvikis D; Ell PJ
Eur J Nucl Med; 2001 Apr; 28(4):478-82. PubMed ID: 11357498
[TBL] [Abstract][Full Text] [Related]
15. [Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors].
Banzo J; Prats E; Razola P; García S; Alonso V; Velilla J; Freile E; Benito JL; García F; Ubieto MA; Tardín L; Abós MD
Rev Esp Med Nucl; 2005; 24(4):278-92. PubMed ID: 16122413
[No Abstract] [Full Text] [Related]
16. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Fujishita T; Kishida M; Taki H; Shinoda C; Miyabayashi K; Fujishita M; Maruyama M; Mizushima Y; Kobayashi M
Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
Okazumi S; Enomoto K; Ozaki M; Yamamoto H; Yoshida M; Abe Y; Takayama W; Yamada S; Isono K; Imazeki K
Kaku Igaku; 1989 Jun; 26(6):793-7. PubMed ID: 2796006
[TBL] [Abstract][Full Text] [Related]
19. Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy.
Nguyen BD; Ram PC
Clin Nucl Med; 2006 Feb; 31(2):101-3. PubMed ID: 16424699
[No Abstract] [Full Text] [Related]
20. 18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
Acevedo-Báñez I; Tirado-Hospital JL; Muñiz-Grijalvo O; Mangas-Cruz MA; García-Gómez FJ
Endocrinol Nutr; 2015 Apr; 62(4):202-4. PubMed ID: 25726370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
